Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
Acrivon Therapeutics, Inc. Common Stock
Market Cap
$80.68M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$81.15M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$79.99M
Net Profit Margin
-430.43%
TTM Avg
-446.97%
3Y Avg
-347.08%
5Y Avg
-386.84%
Market Cap
$79.96M
Net Profit Margin
-648.32%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$81.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-72272.26%
Market Cap
$79.24M
Net Profit Margin
-12.91%
TTM Avg
-907.67%
3Y Avg
-691.25%
5Y Avg
-536.96%
Market Cap
$82.42M
Net Profit Margin
-4560.82%
TTM Avg
-1001.79%
3Y Avg
-692.03%
5Y Avg
-1554.36%
Market Cap
$82.45M
Net Profit Margin
-1168.20%
TTM Avg
-1464.39%
3Y Avg
-946.48%
5Y Avg
-672.82%
Market Cap
$83.02M
Net Profit Margin
57.57%
TTM Avg
-58.69%
3Y Avg
-51.95%
5Y Avg
-56.60%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acrivon Therapeutics, Inc. Common Stock (ACRV) | $80.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $81.15M | 0.00% | 0.00% | 0.00% | 0.00% |
| Nutriband Inc. (NTRB)vs › | $79.99M | -430.43% | -446.97% | -347.08% | -386.84% |
| Citius Oncology, Inc. (CTOR)vs › | $79.96M | -648.32% | 0.00% | 0.00% | 0.00% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $81.88M | 0.00% | 0.00% | 0.00% | -72272.26% |
| vTv Therapeutics Inc. (VTVT)vs › | $79.24M | -12.91% | -907.67% | -691.25% | -536.96% |
| Humacyte, Inc. (HUMA)vs › | $82.42M | -4560.82% | -1001.79% | -692.03% | -1554.36% |
| MediciNova, Inc. (MNOV)vs › | $82.45M | -1168.20% | -1464.39% | -946.48% | -672.82% |
| LENSAR Inc (LNSR)vs › | $83.02M | 57.57% | -58.69% | -51.95% | -56.60% |
| Cardiff Oncology, Inc. (CRDF)vs › | $83.45M | -7884.06% | -7191.86% | -8225.67% | -7676.39% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
